Please use this identifier to cite or link to this item:
Title: Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology.
Authors: Muraro, A
Lemanske, R F
Castells, M
Torres, M J
Khan, D
Simon, H-U
Bindslev-Jensen, C
Burks, W
Poulsen, L K
Sampson, H A
Worm, M
Nadeau, K C
Keywords: allergy;anaphylaxis;endotype;phenotype;precision medicine
metadata.dc.subject.mesh: Age of Onset
Drug Hypersensitivity
Food Hypersensitivity
Precision Medicine
Severity of Illness Index
Issue Date: 12-Apr-2017
Abstract: This consensus document summarizes the current knowledge on the potential for precision medicine in food allergy, drug allergy, and anaphylaxis under the auspices of the PRACTALL collaboration platform. PRACTALL is a joint effort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology, which aims to synchronize the European and American approaches to allergy care. Precision medicine is an emerging approach for disease treatment based on disease endotypes, which are phenotypic subclasses associated with specific mechanisms underlying the disease. Although significant progress has been made in defining endotypes for asthma, definitions of endotypes for food and drug allergy or for anaphylaxis lag behind. Progress has been made in discovery of biomarkers to guide a precision medicine approach to treatment of food and drug allergy, but further validation and quantification of these biomarkers are needed to allow their translation into practice in the clinical management of allergic disease.
metadata.dc.identifier.doi: 10.1111/all.13132
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.